Pathogendx, Inc. is a biotechnology company based in Scottsdale, Arizona, specializing in the development of advanced diagnostic solutions for infectious diseases. The organization focuses on leveraging cutting-edge molecular technologies to enhance the accuracy and speed of pathogen detection. By integrating innovative research methodologies, Pathogendx aims to improve patient outcomes and support healthcare providers in managing infectious threats effectively. Their commitment to precision diagnostics positions them as a key player in the evolving landscape of medical technology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

14 Patents

#57 in Scottsdale, AZ

#277 in Arizona

#22,333 in US

#42,290 in the World

Scottsdale, AZ, United States of America

Pathogendx, Inc.

Forward Citations = 5

8 inventors:

Michael E Hogan (14 out of 45 patents)

Frederick Henry Eggers (12 out of 13 patents)

Melissa Rose May (10 out of 13 patents)

4. Benjamin Alan Katchman (4 out of 5 patents)

5. Candy Mavis Rivas (3 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pathogendx, Inc.. Retrieved from https://idiyas.com/company/pathogendx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]